Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Summary
Franken PR, Block P  
BMIPP imaging for assessing myocardial viability in acute and chronic left ventricular dysfunction

Journal of Clinical and Basic Cardiology 1999; 2 (2): 209-212

PDF    Summary   




Keywords: Fettsäuremyokardiale LebensfähigkeitSPECTfatty acidsmyocardial viabilitysingle photon emission computerized tomography

The use of iodine-123-labeled fatty acids is witnessing a resurgence of interest, primarily because of data from recent clinical protocols comparing regional myocardial uptake of 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP) with flow tracers (either thallium or sestamibi). Mismatches in BMIPP and flow tracer distribution (BMIPP < flow tracer) reflect the metabolic shift from fatty acid to glucose utilization in ischaemic myocardium. In this sense, the combined imaging of BMIPP and a flow tracer with single photon emission computerized tomography (SPECT) may provide similar and equally important information as fluor-18 deoxyglucose and positron emission tomography regarding the assessment of myocardial viability. The purpose of this article is to review the clinical impact of BMIPP in patients with acute and chronic left ventricular dysfunction for the identification of jeopardized but viable myocardium and for the prediction of functional outcome. J Clin Bas Cardiol 1999; 2: 209-12.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung